Antibiotic Developments Insights
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process. Read more
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
AMR in Orthopedics – Benefits of topical treatment and latest advances
Michael Harris, chief executive officer of Biocomposites explores the threat of antibiotic resistance and how antibiotics are being used within the orthopaedics industry. Read more
7 Oct 2021
Improving our approach to fighting AMR
Oliver Schacht, CEO of precision medicine and genomics analysis company OpGen explores what we need to do to improve our fight against antimicrobial resistance (AMR). Read more
11 Aug 2021
The state of bioinformatics in the fight against AMR
Oliver Schacht, CEO of OpGen, Inc., examines the potential of bioinformatics in helping to fight antimicrobial resistance. Read more
27 Jan 2021
Accelerate Diagnostics announces CE marking of its antimicrobial kit
Accelerate Diagnostics, an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, announces CE marking of its new Accelerate Arc Module and BC kit. Read more
8 Aug 2022
Quidel Corp provides rapid clinical detection of C. difficile infection
The Sofia 2 C. difficile FIA (Fluorescent Immunoassay), from healthcare manufacturer Quidel Corporation, provides accurate detection of C. difficile in 15 minutes – half the time of comparator assays – allowing rapid treatment decisions. Read more
1 Jul 2022
Novasep and Paratek increase API manufacture for antibiotic
Technology supplier Novasep and Paratek Pharmaceuticals have signed an agreement to increase the commercial production of an active pharmaceutical ingredient (API) for an antibiotic. Read more
21 Feb 2022
Sponsored Content
Finding therapeutic alternatives to manage neuropathic pain
Henk de Wilde, chief operating officer and R&D Director, iQure Pharma discusses how better understanding of pain is helping researchers to develop novel therapeutics as non-opioid alternatives to manage neuropathic pain. Read more
30 Sep 2022
Tracking sustainability metrics: CDMOs should act now to prevent catch up
EPM spoke exclusively with Heiko Schmidt, Strategy & Consulting Life Sciences lead, Accenture AG, about why CDMOs should be prepared to track sustainability metrics now and how companies which wait, will likely be forced to catch-up at higher costs. Read more
29 Sep 2022
Drug modelling can help provide safer drug therapies for pregnant women
Dr. Karen Rowland Yeo, senior vice president, Client & Regulatory Strategy, Certara UK, describes how pioneering biosimulation is helping to predict drug exposures during pregnancy, providing opportunities for safer care and better outcomes. Read more
28 Sep 2022
PKIs: An early stage treatment for diabetic-related vision loss
Rebekah Jordan fired out some quick Q&As with the Verseon team to shed light on their PKI treatment for diabetic vision loss, its advantages over injection treatments as well as its effectiveness long term. Read more
22 Sep 2022
Unpacking Total Landed Cost to break the habit of paying more for less
Cihan Likogullari, head of EMEA at Envirotainer, explores how calculating Total Landed Cost can help pharma companies make more informed decisions about packaging and the hidden costs that may come alongside it. Read more
22 Sep 2022
Mimicking nature: Automating the cell culture process
Rebekah Jordan sits with Marty Gauvin, CEO of Fertilis, to discuss its IVF treatment innovation that replicates nature and automates the cell culture process, as well as its potential applications in regenerative medicine. Read more
16 Sep 2022
Sponsored Content
Lonza - New Webinar: Solid Form Screening and Rapid Formulation Selection to Meet Demands of Accelerated Timelines
Compare formulation strategy advantages and disadvantages through case studies Read more
1 Jun 2022
White Papers
Sponsored Content
Sponsored Content
Lonza - New Webinar: Solid Form Screening and Rapid Formulation Selection to Meet Demands of Accelerated Timelines
Compare formulation strategy advantages and disadvantages through case studies Read more
1 Jun 2022
Riva-Europe
Suppliers of associated pharmaceutical machinery including tablet R&D tablet presses, capsule filling machines, fluid bed driers, granulators, tablet coating, blenders, roller compactors and powder handling equipment Read more
